Literature DB >> 21233447

Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation.

Jessica Rosati1, Francesco Spallotta, Simona Nanni, Annalisa Grasselli, Annalisa Antonini, Sara Vincenti, Carlo Presutti, Claudia Colussi, Carmen D'Angelo, Anna Biroccio, Antonella Farsetti, Maurizio C Capogrossi, Barbara Illi, Carlo Gaetano.   

Abstract

OBJECTIVE: Smad-interacting protein-1 (Sip1/ZEB2) is a transcriptional repressor of the telomerase reverse transcriptase catalytic subunit (Tert) and has recently been identified as a key regulator of embryonic cell fate with a phenotypic effect similar, in our opinion, to that reported for nitric oxide (NO). Remarkably, SIP1/ZEB2 is a known target of the microRNA 200 (miR-200) family. In this light, we postulated that Sip1/ZEB2 and the miR-200 family could play a role during the NO-dependent differentiation of mES. METHODS AND
RESULTS: The results of the present study show that Sip1/ZEB2 expression is downregulated during the NO-dependent expression of mesendoderm and early cardiovascular precursor markers, including Flk1 and CXCR4 in mES. Coincidently, members of the miR-200 family, namely miR-429, -200a, -200b, and -200c, were transcriptionally induced in parallel to mouse Tert. This regulation occurred at the level of chromatin. Remarkably, miR-429/miR-200a overexpression or Sip1/ZEB2 knockdown by short hairpin RNA interference elicited a gene expression pattern similar to that of NO regardless of the presence of leukemia inhibitory factor.
CONCLUSIONS: These results are the first demonstrating that the miR-200 family and Sip1/ZEB2 transcription factor are regulated by NO, indicating an unprecedented molecular circuitry important for telomerase regulation and early differentiation of mES.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233447     DOI: 10.1161/ATVBAHA.110.214478

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor.

Authors:  Emily Borretto; Loretta Lazzarato; Francesco Spallotta; Chiara Cencioni; Yuri D'Alessandra; Carlo Gaetano; Roberta Fruttero; Alberto Gasco
Journal:  ACS Med Chem Lett       Date:  2013-09-04       Impact factor: 4.345

2.  Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model.

Authors:  Michihiro Toritsuka; Sohei Kimoto; Kazue Muraki; Melissa A Landek-Salgado; Atsuhiro Yoshida; Norio Yamamoto; Yasue Horiuchi; Hideki Hiyama; Katsunori Tajinda; Ni Keni; Elizabeth Illingworth; Takashi Iwamoto; Toshifumi Kishimoto; Akira Sawa; Kenji Tanigaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

3.  Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways.

Authors:  Agnese Re; Simona Nanni; Aurora Aiello; Serena Granata; Claudia Colussi; Giulia Campostrini; Francesco Spallotta; Stefania Mattiussi; Valentina Pantisano; Carmen D'Angelo; Annamaria Biroccio; Alessandra Rossini; Andrea Barbuti; Dario DiFrancesco; Francesco Trimarchi; Alfredo Pontecorvi; Carlo Gaetano; Antonella Farsetti
Journal:  Endocrine       Date:  2015-11-07       Impact factor: 3.633

4.  Zeb1-Hdac2-eNOS circuitry identifies early cardiovascular precursors in naive mouse embryonic stem cells.

Authors:  Chiara Cencioni; Francesco Spallotta; Matteo Savoia; Carsten Kuenne; Stefan Guenther; Agnese Re; Susanne Wingert; Maike Rehage; Duran Sürün; Mauro Siragusa; Jacob G Smith; Frank Schnütgen; Harald von Melchner; Michael A Rieger; Fabio Martelli; Antonella Riccio; Ingrid Fleming; Thomas Braun; Andreas M Zeiher; Antonella Farsetti; Carlo Gaetano
Journal:  Nat Commun       Date:  2018-03-29       Impact factor: 14.919

5.  Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells.

Authors:  Sara Beji; Giuseppina Milano; Alessandro Scopece; Lucia Cicchillitti; Chiara Cencioni; Mario Picozza; Yuri D'Alessandra; Sarah Pizzolato; Matteo Bertolotti; Gabriella Spaltro; Angela Raucci; Giulia Piaggio; Giulio Pompilio; Maurizio C Capogrossi; Daniele Avitabile; Alessandra Magenta; Elisa Gambini
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

Review 6.  Stem cells and new intervention measures as emerging therapy in cardiac surgery.

Authors:  Calogera Pisano; Paolo Nardi; Carmela Rita Balistreri; Claudia Altieri; Fabio Bertoldo; Giovanni Ruvolo
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-04-09

7.  In vitro epigenetic reprogramming of human cardiac mesenchymal stromal cells into functionally competent cardiovascular precursors.

Authors:  Matteo Vecellio; Viviana Meraviglia; Simona Nanni; Andrea Barbuti; Angela Scavone; Dario DiFrancesco; Antonella Farsetti; Giulio Pompilio; Gualtiero I Colombo; Maurizio C Capogrossi; Carlo Gaetano; Alessandra Rossini
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

Review 8.  Oxidative stress and microRNAs in vascular diseases.

Authors:  Alessandra Magenta; Simona Greco; Carlo Gaetano; Fabio Martelli
Journal:  Int J Mol Sci       Date:  2013-08-22       Impact factor: 5.923

Review 9.  Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction.

Authors:  Alessandra Magenta; Simona Greco; Maurizio C Capogrossi; Carlo Gaetano; Fabio Martelli
Journal:  Biomed Res Int       Date:  2014-03-05       Impact factor: 3.411

10.  Establishing reliable miRNA-cancer association network based on text-mining method.

Authors:  Lun Li; Xingchi Hu; Zhaowan Yang; Zhenyu Jia; Ming Fang; Libin Zhang; Yanhong Zhou
Journal:  Comput Math Methods Med       Date:  2014-04-10       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.